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5α-dihydrotestosterone and the Wnt/β-catenin pathway in  
Danio rerio ovarian tissue following 2 and 4 hour incubations 
• The Wnt/β-catenin pathway regulates genes involved 
in cell proliferation and apoptosis, hallmarks of cancer 
cells1 
• This pathway is implicated in ovarian cancer and is 
used as a marker for Epithelial Ovarian Cancer 
(EOC)1 
• High levels of β-catenin may be involved in tumor 
development2 
• Ovarian epithelium displays high quantities of 
androgen receptors and thus may be more 
susceptible to changes in testosterone concentration3 
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• Collect ovary tissue from zebrafish (Danio rerio) and incubate in  
60% L-15 medium (with 1x antibiotic/antimycotic) and 5α-
dihydrotestosterone (0, 1, 10, 100 ng/mL) at 26 °C for 2 or 4 hours 
• Extract mRNA and convert to cDNA (50 ng/μL)  
• Perform qPCR to quantify relative concentrations of β-catenin and 
GSK-3β mRNA present in the ovary tissue 
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Figure 2. Expression of β-catenin and GSK-3β mRNA in ovarian tissue following a 2 hr (left) and 4 hr (right) incubation 
in different concentrations of DHT. Three fish were collected per experiment, with three technical replicates per 
specimen. Extensive error bars may be due to the biological variance among specimens, as well as the diversity of 
tissue present in ovarian tissue. Expression was normalized to the reference gene β-actin. T-tests were used for 
statistical analysis, where statistical significance compares treated tissue (1, 10, 100 ng/mL) to untreated tissue (0 
ng/mL). Untreated tissue was arbitrarily set at 1 to demonstrate fold differences in expression. *p<0.05; **p<0.01 
• Learn qPCR technique and 
design/optimize primers that identify β-
catenin and GSK-3β mRNA 
• Monitor the effect of DHT on the Wnt/β-
catenin pathway at different time points 
using qPCR analysis 
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Figure 1. The Wnt/β-catenin signaling pathway in cells. 
When Wnt is activated, it interacts with other proteins in 
the cell to inhibit GSK-3β, which causes an increase of β-
catenin in the cell. Excess β-catenin translocates to the 
nucleus, where it increases gene transcription for cellular 
proliferation and decreases gene transcription for 
apoptosis. When Wnt is not activated, GSK-3β 
phosphorylates β-catenin, causing it to be degraded by a 
proteasome. Dashed figures indicate structures involved in 
the pathway, but not analyzed in this project. Figure 
adapted from Arend et al., 2013.4 
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* 
• Longer (4 hr) exposure to DHT may lead to inhibition of the Wnt/β-catenin pathway 
• Significantly less β-catenin and GSK-3β in all 3 treatments 
• Shorter (2 hr) exposure produced no statistical significance, possibly due to… 
• Biological variance among specimens 
• Too short of an exposure time, where the effects of DHT have yet to take place 
• Future directions include… 
• Quantifying the relative concentrations of β-catenin and GSK-3β proteins in ovarian tissue at 2 and 4 hrs 
using Western Blot technique 
• Designing primers for genes regulated by the Wnt/β-catenin pathway and performing qPCR to investigate 
if any regulation is occurring in the presence of DHT 
* 
** 
This study investigated whether exogenous 
5α-dihydrotestosterone (DHT) utilizes the Wnt/β-catenin 
pathway by monitoring β-catenin and GSK-3β mRNA 
expression through quantitative (q)PCR analysis. Data 
showed that the concentrations of β-catenin and GSK-3β 
mRNA varied between both time points and 
concentrations of DHT. 
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